 | • レポートコード：QFJ1-5286 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、排卵障害診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン検査、視床下部検出、卵巣生検、その他）、用途別市場規模（病院、婦人科クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・排卵障害診断の市場動向 ・企業の競争状況、市場シェア ・排卵障害診断の種類別市場規模と予測2016-2027（ホルモン検査、視床下部検出、卵巣生検、その他） ・排卵障害診断の用途別市場規模と予測2016-2027（病院、婦人科クリニック） ・排卵障害診断の北米市場規模2016-2027（アメリカ、カナダ） ・排卵障害診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・排卵障害診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・排卵障害診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・排卵障害診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Siemens Healthcare、GE Healthcare、Fujifilm Holdings、Swiss Precision Diagnostics、Canon Medical System、Carestream Health、Genova Diagnostics、Quest Diagnostics、LabCorp、Esaote） ・結論 |
Some significant driving factors for the growth of the ovulation disorder diagnosis market include increasing genetic and hormonal disorders, rising obesity rates, the increasing prevalence of diabetes around the world.
Market Analysis and Insights: Global Ovulation Disorder Diagnosis Market
The global Ovulation Disorder Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ovulation Disorder Diagnosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ovulation Disorder Diagnosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ovulation Disorder Diagnosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ovulation Disorder Diagnosis market.
Global Ovulation Disorder Diagnosis Scope and Market Size
Ovulation Disorder Diagnosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ovulation Disorder Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Hormone Test
Hypothalamus Detection
Ovarian Biopsy
Other
Segment by Application
Hospitals
Gynecological Clinics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Siemens Healthcare
GE Healthcare
Fujifilm Holdings
Swiss Precision Diagnostics
Canon Medical System
Carestream Health
Genova Diagnostics
Quest Diagnostics
LabCorp
Esaote
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ovulation Disorder Diagnosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormone Test
1.2.3 Hypothalamus Detection
1.2.4 Ovarian Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Ovulation Disorder Diagnosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Gynecological Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ovulation Disorder Diagnosis Market Perspective (2016-2027)
2.2 Ovulation Disorder Diagnosis Growth Trends by Regions
2.2.1 Ovulation Disorder Diagnosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ovulation Disorder Diagnosis Historic Market Share by Regions (2016-2021)
2.2.3 Ovulation Disorder Diagnosis Forecasted Market Size by Regions (2022-2027)
2.3 Ovulation Disorder Diagnosis Industry Dynamic
2.3.1 Ovulation Disorder Diagnosis Market Trends
2.3.2 Ovulation Disorder Diagnosis Market Drivers
2.3.3 Ovulation Disorder Diagnosis Market Challenges
2.3.4 Ovulation Disorder Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ovulation Disorder Diagnosis Players by Revenue
3.1.1 Global Top Ovulation Disorder Diagnosis Players by Revenue (2016-2021)
3.1.2 Global Ovulation Disorder Diagnosis Revenue Market Share by Players (2016-2021)
3.2 Global Ovulation Disorder Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ovulation Disorder Diagnosis Revenue
3.4 Global Ovulation Disorder Diagnosis Market Concentration Ratio
3.4.1 Global Ovulation Disorder Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ovulation Disorder Diagnosis Revenue in 2020
3.5 Ovulation Disorder Diagnosis Key Players Head office and Area Served
3.6 Key Players Ovulation Disorder Diagnosis Product Solution and Service
3.7 Date of Enter into Ovulation Disorder Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ovulation Disorder Diagnosis Breakdown Data by Type
4.1 Global Ovulation Disorder Diagnosis Historic Market Size by Type (2016-2021)
4.2 Global Ovulation Disorder Diagnosis Forecasted Market Size by Type (2022-2027)
5 Ovulation Disorder Diagnosis Breakdown Data by Application
5.1 Global Ovulation Disorder Diagnosis Historic Market Size by Application (2016-2021)
5.2 Global Ovulation Disorder Diagnosis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Ovulation Disorder Diagnosis Market Size (2016-2027)
6.2 North America Ovulation Disorder Diagnosis Market Size by Type
6.2.1 North America Ovulation Disorder Diagnosis Market Size by Type (2016-2021)
6.2.2 North America Ovulation Disorder Diagnosis Market Size by Type (2022-2027)
6.2.3 North America Ovulation Disorder Diagnosis Market Size by Type (2016-2027)
6.3 North America Ovulation Disorder Diagnosis Market Size by Application
6.3.1 North America Ovulation Disorder Diagnosis Market Size by Application (2016-2021)
6.3.2 North America Ovulation Disorder Diagnosis Market Size by Application (2022-2027)
6.3.3 North America Ovulation Disorder Diagnosis Market Size by Application (2016-2027)
6.4 North America Ovulation Disorder Diagnosis Market Size by Country
6.4.1 North America Ovulation Disorder Diagnosis Market Size by Country (2016-2021)
6.4.2 North America Ovulation Disorder Diagnosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Ovulation Disorder Diagnosis Market Size (2016-2027)
7.2 Europe Ovulation Disorder Diagnosis Market Size by Type
7.2.1 Europe Ovulation Disorder Diagnosis Market Size by Type (2016-2021)
7.2.2 Europe Ovulation Disorder Diagnosis Market Size by Type (2022-2027)
7.2.3 Europe Ovulation Disorder Diagnosis Market Size by Type (2016-2027)
7.3 Europe Ovulation Disorder Diagnosis Market Size by Application
7.3.1 Europe Ovulation Disorder Diagnosis Market Size by Application (2016-2021)
7.3.2 Europe Ovulation Disorder Diagnosis Market Size by Application (2022-2027)
7.3.3 Europe Ovulation Disorder Diagnosis Market Size by Application (2016-2027)
7.4 Europe Ovulation Disorder Diagnosis Market Size by Country
7.4.1 Europe Ovulation Disorder Diagnosis Market Size by Country (2016-2021)
7.4.2 Europe Ovulation Disorder Diagnosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Ovulation Disorder Diagnosis Market Size (2016-2027)
8.2 Asia-Pacific Ovulation Disorder Diagnosis Market Size by Type
8.2.1 Asia-Pacific Ovulation Disorder Diagnosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ovulation Disorder Diagnosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ovulation Disorder Diagnosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Ovulation Disorder Diagnosis Market Size by Application
8.3.1 Asia-Pacific Ovulation Disorder Diagnosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ovulation Disorder Diagnosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ovulation Disorder Diagnosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Ovulation Disorder Diagnosis Market Size by Region
8.4.1 Asia-Pacific Ovulation Disorder Diagnosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ovulation Disorder Diagnosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ovulation Disorder Diagnosis Market Size (2016-2027)
9.2 Latin America Ovulation Disorder Diagnosis Market Size by Type
9.2.1 Latin America Ovulation Disorder Diagnosis Market Size by Type (2016-2021)
9.2.2 Latin America Ovulation Disorder Diagnosis Market Size by Type (2022-2027)
9.2.3 Latin America Ovulation Disorder Diagnosis Market Size by Type (2016-2027)
9.3 Latin America Ovulation Disorder Diagnosis Market Size by Application
9.3.1 Latin America Ovulation Disorder Diagnosis Market Size by Application (2016-2021)
9.3.2 Latin America Ovulation Disorder Diagnosis Market Size by Application (2022-2027)
9.3.3 Latin America Ovulation Disorder Diagnosis Market Size by Application (2016-2027)
9.4 Latin America Ovulation Disorder Diagnosis Market Size by Country
9.4.1 Latin America Ovulation Disorder Diagnosis Market Size by Country (2016-2021)
9.4.2 Latin America Ovulation Disorder Diagnosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ovulation Disorder Diagnosis Market Size (2016-2027)
10.2 Middle East & Africa Ovulation Disorder Diagnosis Market Size by Type
10.2.1 Middle East & Africa Ovulation Disorder Diagnosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ovulation Disorder Diagnosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ovulation Disorder Diagnosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Ovulation Disorder Diagnosis Market Size by Application
10.3.1 Middle East & Africa Ovulation Disorder Diagnosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ovulation Disorder Diagnosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ovulation Disorder Diagnosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Ovulation Disorder Diagnosis Market Size by Country
10.4.1 Middle East & Africa Ovulation Disorder Diagnosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ovulation Disorder Diagnosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Siemens Healthcare
11.1.1 Siemens Healthcare Company Details
11.1.2 Siemens Healthcare Business Overview
11.1.3 Siemens Healthcare Ovulation Disorder Diagnosis Introduction
11.1.4 Siemens Healthcare Revenue in Ovulation Disorder Diagnosis Business (2016-2021)
11.1.5 Siemens Healthcare Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Ovulation Disorder Diagnosis Introduction
11.2.4 GE Healthcare Revenue in Ovulation Disorder Diagnosis Business (2016-2021)
11.2.5 GE Healthcare Recent Development
11.3 Fujifilm Holdings
11.3.1 Fujifilm Holdings Company Details
11.3.2 Fujifilm Holdings Business Overview
11.3.3 Fujifilm Holdings Ovulation Disorder Diagnosis Introduction
11.3.4 Fujifilm Holdings Revenue in Ovulation Disorder Diagnosis Business (2016-2021)
11.3.5 Fujifilm Holdings Recent Development
11.4 Swiss Precision Diagnostics
11.4.1 Swiss Precision Diagnostics Company Details
11.4.2 Swiss Precision Diagnostics Business Overview
11.4.3 Swiss Precision Diagnostics Ovulation Disorder Diagnosis Introduction
11.4.4 Swiss Precision Diagnostics Revenue in Ovulation Disorder Diagnosis Business (2016-2021)
11.4.5 Swiss Precision Diagnostics Recent Development
11.5 Canon Medical System
11.5.1 Canon Medical System Company Details
11.5.2 Canon Medical System Business Overview
11.5.3 Canon Medical System Ovulation Disorder Diagnosis Introduction
11.5.4 Canon Medical System Revenue in Ovulation Disorder Diagnosis Business (2016-2021)
11.5.5 Canon Medical System Recent Development
11.6 Carestream Health
11.6.1 Carestream Health Company Details
11.6.2 Carestream Health Business Overview
11.6.3 Carestream Health Ovulation Disorder Diagnosis Introduction
11.6.4 Carestream Health Revenue in Ovulation Disorder Diagnosis Business (2016-2021)
11.6.5 Carestream Health Recent Development
11.7 Genova Diagnostics
11.7.1 Genova Diagnostics Company Details
11.7.2 Genova Diagnostics Business Overview
11.7.3 Genova Diagnostics Ovulation Disorder Diagnosis Introduction
11.7.4 Genova Diagnostics Revenue in Ovulation Disorder Diagnosis Business (2016-2021)
11.7.5 Genova Diagnostics Recent Development
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Details
11.8.2 Quest Diagnostics Business Overview
11.8.3 Quest Diagnostics Ovulation Disorder Diagnosis Introduction
11.8.4 Quest Diagnostics Revenue in Ovulation Disorder Diagnosis Business (2016-2021)
11.8.5 Quest Diagnostics Recent Development
11.9 LabCorp
11.9.1 LabCorp Company Details
11.9.2 LabCorp Business Overview
11.9.3 LabCorp Ovulation Disorder Diagnosis Introduction
11.9.4 LabCorp Revenue in Ovulation Disorder Diagnosis Business (2016-2021)
11.9.5 LabCorp Recent Development
11.10 Esaote
11.10.1 Esaote Company Details
11.10.2 Esaote Business Overview
11.10.3 Esaote Ovulation Disorder Diagnosis Introduction
11.10.4 Esaote Revenue in Ovulation Disorder Diagnosis Business (2016-2021)
11.10.5 Esaote Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Ovulation Disorder Diagnosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormone Test
Table 3. Key Players of Hypothalamus Detection
Table 4. Key Players of Ovarian Biopsy
Table 5. Key Players of Other
Table 6. Global Ovulation Disorder Diagnosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ovulation Disorder Diagnosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Ovulation Disorder Diagnosis Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Ovulation Disorder Diagnosis Market Share by Regions (2016-2021)
Table 10. Global Ovulation Disorder Diagnosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Ovulation Disorder Diagnosis Market Share by Regions (2022-2027)
Table 12. Ovulation Disorder Diagnosis Market Trends
Table 13. Ovulation Disorder Diagnosis Market Drivers
Table 14. Ovulation Disorder Diagnosis Market Challenges
Table 15. Ovulation Disorder Diagnosis Market Restraints
Table 16. Global Ovulation Disorder Diagnosis Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Ovulation Disorder Diagnosis Market Share by Players (2016-2021)
Table 18. Global Top Ovulation Disorder Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovulation Disorder Diagnosis as of 2020)
Table 19. Ranking of Global Top Ovulation Disorder Diagnosis Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Ovulation Disorder Diagnosis Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Ovulation Disorder Diagnosis Product Solution and Service
Table 23. Date of Enter into Ovulation Disorder Diagnosis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ovulation Disorder Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Ovulation Disorder Diagnosis Revenue Market Share by Type (2016-2021)
Table 27. Global Ovulation Disorder Diagnosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Ovulation Disorder Diagnosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Ovulation Disorder Diagnosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Ovulation Disorder Diagnosis Revenue Market Share by Application (2016-2021)
Table 31. Global Ovulation Disorder Diagnosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Ovulation Disorder Diagnosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Ovulation Disorder Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Ovulation Disorder Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Ovulation Disorder Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Ovulation Disorder Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Ovulation Disorder Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Ovulation Disorder Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Ovulation Disorder Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Ovulation Disorder Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Ovulation Disorder Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Ovulation Disorder Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Ovulation Disorder Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Ovulation Disorder Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ovulation Disorder Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ovulation Disorder Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ovulation Disorder Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Ovulation Disorder Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Ovulation Disorder Diagnosis Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Ovulation Disorder Diagnosis Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Ovulation Disorder Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Ovulation Disorder Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Ovulation Disorder Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Ovulation Disorder Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Ovulation Disorder Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Ovulation Disorder Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ovulation Disorder Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ovulation Disorder Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ovulation Disorder Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Ovulation Disorder Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Ovulation Disorder Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Ovulation Disorder Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 63. Siemens Healthcare Company Details
Table 64. Siemens Healthcare Business Overview
Table 65. Siemens Healthcare Ovulation Disorder Diagnosis Product
Table 66. Siemens Healthcare Revenue in Ovulation Disorder Diagnosis Business (2016-2021) & (US$ Million)
Table 67. Siemens Healthcare Recent Development
Table 68. GE Healthcare Company Details
Table 69. GE Healthcare Business Overview
Table 70. GE Healthcare Ovulation Disorder Diagnosis Product
Table 71. GE Healthcare Revenue in Ovulation Disorder Diagnosis Business (2016-2021) & (US$ Million)
Table 72. GE Healthcare Recent Development
Table 73. Fujifilm Holdings Company Details
Table 74. Fujifilm Holdings Business Overview
Table 75. Fujifilm Holdings Ovulation Disorder Diagnosis Product
Table 76. Fujifilm Holdings Revenue in Ovulation Disorder Diagnosis Business (2016-2021) & (US$ Million)
Table 77. Fujifilm Holdings Recent Development
Table 78. Swiss Precision Diagnostics Company Details
Table 79. Swiss Precision Diagnostics Business Overview
Table 80. Swiss Precision Diagnostics Ovulation Disorder Diagnosis Product
Table 81. Swiss Precision Diagnostics Revenue in Ovulation Disorder Diagnosis Business (2016-2021) & (US$ Million)
Table 82. Swiss Precision Diagnostics Recent Development
Table 83. Canon Medical System Company Details
Table 84. Canon Medical System Business Overview
Table 85. Canon Medical System Ovulation Disorder Diagnosis Product
Table 86. Canon Medical System Revenue in Ovulation Disorder Diagnosis Business (2016-2021) & (US$ Million)
Table 87. Canon Medical System Recent Development
Table 88. Carestream Health Company Details
Table 89. Carestream Health Business Overview
Table 90. Carestream Health Ovulation Disorder Diagnosis Product
Table 91. Carestream Health Revenue in Ovulation Disorder Diagnosis Business (2016-2021) & (US$ Million)
Table 92. Carestream Health Recent Development
Table 93. Genova Diagnostics Company Details
Table 94. Genova Diagnostics Business Overview
Table 95. Genova Diagnostics Ovulation Disorder Diagnosis Product
Table 96. Genova Diagnostics Revenue in Ovulation Disorder Diagnosis Business (2016-2021) & (US$ Million)
Table 97. Genova Diagnostics Recent Development
Table 98. Quest Diagnostics Company Details
Table 99. Quest Diagnostics Business Overview
Table 100. Quest Diagnostics Revenue in Ovulation Disorder Diagnosis Business (2016-2021) & (US$ Million)
Table 101. Quest Diagnostics Recent Development
Table 102. LabCorp Company Details
Table 103. LabCorp Business Overview
Table 104. LabCorp Ovulation Disorder Diagnosis Product
Table 105. LabCorp Revenue in Ovulation Disorder Diagnosis Business (2016-2021) & (US$ Million)
Table 106. LabCorp Recent Development
Table 107. Esaote Company Details
Table 108. Esaote Business Overview
Table 109. Esaote Ovulation Disorder Diagnosis Product
Table 110. Esaote Revenue in Ovulation Disorder Diagnosis Business (2016-2021) & (US$ Million)
Table 111. Esaote Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ovulation Disorder Diagnosis Market Share by Type: 2020 VS 2027
Figure 2. Hormone Test Features
Figure 3. Hypothalamus Detection Features
Figure 4. Ovarian Biopsy Features
Figure 5. Other Features
Figure 6. Global Ovulation Disorder Diagnosis Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Gynecological Clinics Case Studies
Figure 9. Ovulation Disorder Diagnosis Report Years Considered
Figure 10. Global Ovulation Disorder Diagnosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Ovulation Disorder Diagnosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Ovulation Disorder Diagnosis Market Share by Regions: 2020 VS 2027
Figure 13. Global Ovulation Disorder Diagnosis Market Share by Regions (2022-2027)
Figure 14. Global Ovulation Disorder Diagnosis Market Share by Players in 2020
Figure 15. Global Top Ovulation Disorder Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovulation Disorder Diagnosis as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Ovulation Disorder Diagnosis Revenue in 2020
Figure 17. Global Ovulation Disorder Diagnosis Revenue Market Share by Type (2016-2021)
Figure 18. Global Ovulation Disorder Diagnosis Revenue Market Share by Type (2022-2027)
Figure 19. North America Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Ovulation Disorder Diagnosis Market Share by Type (2016-2027)
Figure 21. North America Ovulation Disorder Diagnosis Market Share by Application (2016-2027)
Figure 22. North America Ovulation Disorder Diagnosis Market Share by Country (2016-2027)
Figure 23. United States Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Ovulation Disorder Diagnosis Market Share by Type (2016-2027)
Figure 27. Europe Ovulation Disorder Diagnosis Market Share by Application (2016-2027)
Figure 28. Europe Ovulation Disorder Diagnosis Market Share by Country (2016-2027)
Figure 29. Germany Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Ovulation Disorder Diagnosis Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Ovulation Disorder Diagnosis Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Ovulation Disorder Diagnosis Market Share by Region (2016-2027)
Figure 39. China Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Ovulation Disorder Diagnosis Market Share by Type (2016-2027)
Figure 47. Latin America Ovulation Disorder Diagnosis Market Share by Application (2016-2027)
Figure 48. Latin America Ovulation Disorder Diagnosis Market Share by Country (2016-2027)
Figure 49. Mexico Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Ovulation Disorder Diagnosis Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Ovulation Disorder Diagnosis Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Ovulation Disorder Diagnosis Market Share by Country (2016-2027)
Figure 55. Turkey Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Ovulation Disorder Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Siemens Healthcare Revenue Growth Rate in Ovulation Disorder Diagnosis Business (2016-2021)
Figure 59. GE Healthcare Revenue Growth Rate in Ovulation Disorder Diagnosis Business (2016-2021)
Figure 60. Fujifilm Holdings Revenue Growth Rate in Ovulation Disorder Diagnosis Business (2016-2021)
Figure 61. Swiss Precision Diagnostics Revenue Growth Rate in Ovulation Disorder Diagnosis Business (2016-2021)
Figure 62. Canon Medical System Revenue Growth Rate in Ovulation Disorder Diagnosis Business (2016-2021)
Figure 63. Carestream Health Revenue Growth Rate in Ovulation Disorder Diagnosis Business (2016-2021)
Figure 64. Genova Diagnostics Revenue Growth Rate in Ovulation Disorder Diagnosis Business (2016-2021)
Figure 65. Quest Diagnostics Revenue Growth Rate in Ovulation Disorder Diagnosis Business (2016-2021)
Figure 66. LabCorp Revenue Growth Rate in Ovulation Disorder Diagnosis Business (2016-2021)
Figure 67. Esaote Revenue Growth Rate in Ovulation Disorder Diagnosis Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
排卵検査のグローバル市場2021 Ovulation tests or ovulation predictor kits (OPKs) are tests that allow users to predict ovulatory period. Ovulation tests work by detecting luteinizing hormone (LH). Just preceding ovulation, women experience an "LH surge" - a sudden, dramatic, and brief rise in the level of luteinizing hormone. Fi…- 世界の甲状腺障害市場規模・現状・予測（2021年-2027年） Thyroid disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism, hyperthyroidism, etc. falling under the category of thyroid disorders. The global thyroid disorder market is estimated to be driven by the increasing prevalence of …
- 世界の神経疾患診断市場規模・現状・予測（2021年-2027年） Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders. Market Analysis and Insights: Global Neurological Disorder Diagnostics Market The global Neurological Disorder Diagnostics market size is projected to reach US$ 13800 million by 2027, from US$ 10080 mi…
- 世界のHPV関連疾患市場規模・現状・予測（2021年-2027年） HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby. Market Analysis and Insights: Global HPV Associated Disorder Market The global HPV Associated Disorder market size is projected to reach US$ XX million by 2027, from US…
- 世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年） CDKL5 deficiency disorder (CDD) is a rare developmental epileptic encephalopathy (DEE), X-linked genetic condition which results in early-onset, difficult to control seizures and severe neuro-developmental impairment. CDKL5 stands for cyclin-dependent kinase-like 5 and mutations in this gene were fi…